Increase in tumour permeability following TGF-β type I receptor-inhibitor treatment observed by dynamic contrast-enhanced MRI

BACKGROUND: To enhance the success rate of nanocarrier-mediated chemotherapy combined with an anti-angiogenic agent, it is crucial to identify parameters for tumour vasculature that can predict a response to the treatment of the anti-angiogenic agent. METHODS: To apply transforming growth factor (TG...

Descripción completa

Detalles Bibliográficos
Autores principales: Minowa, T, Kawano, K, Kuribayashi, H, Shiraishi, K, Sugino, T, Hattori, Y, Yokoyama, M, Maitani, Y
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788254/
https://www.ncbi.nlm.nih.gov/pubmed/19888220
http://dx.doi.org/10.1038/sj.bjc.6605367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788254/
https://www.ncbi.nlm.nih.gov/pubmed/19888220
http://dx.doi.org/10.1038/sj.bjc.6605367

Ejemplares similares